Precision Diagnostics Market 2020 Growth Projection by Leading Players: Pfizer, Novartis, Sanofi, Bayer AG, GlaxoSmithKline plc., Boehringer Ingelheim International GmbH, Bluebird bio, Inc., uniQure N.V., Amgen Inc., CELGENE CORPORATION

Global Precision Diagnostics Market Size, Share and Global Trend By Type (Genetic tests, Esoteric tests), End Users (Hospitals, Clinical laboratories) and Geography Forecast till 2026.

To know How COVID-19 Pandemic Will Impact This Market/Industry -Request a sample copy of the report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/precision-diagnostics-market-100357

Leading Players operating in the Precision Diagnostics Market are:

Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are: Pfizer, Novartis, Sanofi, Bayer AG, GlaxoSmithKline plc., Boehringer Ingelheim International GmbH, Bluebird bio, Inc., uniQure N.V., Amgen Inc., CELGENE CORPORATION.

Government-backed Investments and Presence of a Well-equipped Infrastructure Encourage Growth in North America

Among regions, North America is anticipated to dominate the global precision diagnostics market between 2018 and 2026. The presence of a well-established healthcare infrastructure in the region is driving the market. This, coupled with rising governments support for the development of precision diagnostics, enhances the market's growth. In addition to this, the rising number of research and development (R&D) investments by government bodies is expected to register growth in the market by 2026.

Market Progresses with DxTerity's Launch of a New AIP Test for Home Patients

"Recent advancements in gene therapy such as gene sequencing, companion diagnostics among others can help to treat severe illness," stated a lead analyst at Fortune Business Insights. "Development of precision therapies for the treatment of cancer and Alzheimer's is likely to contribute to the revenue of the global market," he added. The rising prevalence of neurological disorders is also expected to fuel demand for precision diagnosis in the forecast horizon. Companies are also planning to focus on strategies to develop precision medicines, catering to specific patient's requirements. For instance, DxTerity Diagnostics Inc. developed a new test called autoimmune profile (AIP) test in October 2018. This test is cost-effective and is catered to home patients. Tailor-made precision diagnosis of acute infectious diseases medicine is anticipated to gain popularity as these medicines fit in every individual's frame. This will further drive the precision diagnostics market.

Precision Diagnostics Market Report Covers Major Insights:

Key drivers, restraints, and prevailing Precision Diagnostics Market trends
Precision Diagnostics Market size, growth rate, and opportunities
Precision Diagnostics Market share and position of the top players
PEST Analysis of the five major regions
Detailed SWOT analysis of top companies
Recent developments and new product launches
Major challenges faced by the market players
Precision Diagnostics Market report also include data type such as capacity, production, market share, price, growth rate, consumption, import, export etc. Industry chain, manufacturing process, cost structure, marketing channel are also analysed in this report.

Market Segment by Regional Analysis covers:

North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
The global Precision Diagnostics market is anticipated to rise at a considerable rate during the forecast period, between 2020 and 2024. In 2020, the market was growing at a steady rate and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Table of Contents

1 Market Overview

1.1 Precision Diagnostics Introduction

1.2 Market Analysis by Type

1.3 Market Analysis by Applications

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.4 South America, Middle East and Africa

1.5 Market Dynamics

Click here to get the short-term and long-term impact of COVID-19 on this Precision Diagnostics Market: https://www.fortunebusinessinsights.com/industry-reports/precision-diagnostics-market-100357

About us:

Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

Contact Us:

Fortune Business Insights Pvt. Ltd.

Supreme Headquarters,

Pune Banglore Highway, Baner, Pune,

Maharashtra 411045, India

US: +1 424 253 0390

UK: +44 2071 939123

APAC: +91 744 740 1245

Email: sales@fortunebusinessinsights.com

Pune Banglore Highway Pashan Exit, Baner, Pune, Maharashtra 411045, India

Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

This release was published on openPR.